Company intelligence / Profile preview
SeraGene Therapeutics
Worcester, Massachusetts, United Statesseragene.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
SeraGene Therapeutics is a pre-clinical stage biotechnology company focused on developing next-generation RNA interference (RNAi) therapies for severe neurological disorders. Spun out from the University of Massachusetts Chan Medical School, the company utilizes a proprietary hydrophobically modified small interfering RNA (hsiRNA) platform designed to achieve broad and efficient distribution within the central nervous system. Their lead programs target neurodegenerative conditions such as Huntington's disease and Amyotrophic Lateral Sclerosis (ALS) by silencing disease-causing genes. SeraGene aims to overcome traditional delivery barriers in the brain to provide transformative treatments for patients with limited options.
- Therapeutic areas
- Neurology
- Modalities
- RNA therapySmall interfering RNA
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on SeraGene Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SeraGene Therapeutics.